PATENT CLAIM ANALYSIS

Application Number: 16228130
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["558", "070000"]

Abstract:
Cell binding agent-drug conjugates comprising phosphinate-based charged linkers and methods of using such linkers and conjugates are provided.

Claim (Index 8):
The cell-binding agent-drug conjugate of  claim 7 , wherein the tumor cells are selected from the group consisting of lymphoma cells, myeloma cells, renal cells, breast cancer cells, prostate cancer cells, ovarian cancer cells, colorectal cancer cells, gastric cancer cells, squamous cancer cells, small-cell lung cancer cells, testicular cancer cells, or any cells that grow and divide at an unregulated, quickened pace to cause cancers.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.1875
- Patent Class: 558.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14432073', '16228437', '16228310', '15118726', '13542126']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8546308759352049
- 35 USC 102 Novelty (BERT): 0.6268164563240272
- Combined Prediction Score: 0.8318494339740872
- Mean Citation Score: 607.8427720000002
- Max Citation Score: 658.0060000000002
- Similarity Product: 466.9195094369652

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test